Madhav Chopra
Pulmonary Disease · Phoenix, AZNPI 1760877914
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (33.1%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Intuitive Surgical at 48.0% of the total.
Across 66 payments — averaging $303.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$10K
- Sanofi$4K
- Steris Corporation$2K
- Pulmonx Corporation$1K
- Pinnacle Biologics, Inc$1K
- Johnson & Johnson$394
- plus $554 from 5 others
What the payments were for
- Consulting fees$4,21621%
- Travel & lodging$6,06430%
- Food & beverage$3,11816%
- Education$6,62533%
- Gifts$90%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 34 | $9,607 |
| Sanofi | 6 | $4,490 |
| Steris Corporation | 5 | $2,446 |
| Pulmonx Corporation | 6 | $1,409 |
| Pinnacle Biologics, Inc | 6 | $1,132 |
| Johnson & Johnson(2 entities) | 3 | $394 |
| Baxter Healthcare | 2 | $230 |
| Merit Medical Systems Inc | 1 | $119 |
| Atricure, Inc. | 1 | $87 |
| Gyrus ACMI, Inc. | 1 | $60 |
| Olympus America Inc. | 1 | $59 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$5,898
- ION$3,000
- TRUFREEZE$2,387
- ZEPHYR ENDOBRONCHIAL VALVE$1,317
- Photofrin$1,010
- Monarch Platform$152
- ZIPFIX$148
- MATRIXRIB$148
- AEROmini Stent and Delivery System$119
- BIG60 Inflation device$119
- Elation Balloon Dilator$119
- PREVELEAK$118
- COSEAL$111
- CHARTIS CATHETER$109
- ZEPHYR DELIVERY CATHETER$109
- PULMONX CHARTIS TABLET CONSOLE$109
How this compares
$20,032 in reported general payments places this provider in the 85th percentile of 250 pulmonary disease providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 148 | $132,956 |
| ZemairaAlpha-1-Proteinase Inhibitor | 11 | $75,073 |
| Spiriva RespimatTiotropium Bromide | 90 | $54,331 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 74 | $51,973 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 48 | $31,763 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 33 | $23,045 |
| SymbicortBudesonide/Formoterol Fumarate | 45 | $12,695 |
| Advair HfaFluticasone Propion/Salmeterol | 32 | $12,399 |
| Breo ElliptaFluticasone/Vilanterol | 12 | $4,586 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 143 | $3,116 |
| Wixela InhubFluticasone Propion/Salmeterol | 21 | $1,503 |
| Roflumilast | 12 | $714 |
| Fluticasone Propionate | 19 | $242 |
| Montelukast Sodium | 13 | $186 |
| Azithromycin | 50 | $124 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in Phoenix
- Rajat WaliaPhoenix$748K
- Brian PorvinPhoenix$276K
- Abid KhokarPhoenix$262K
- Tony HodgesPhoenix$248K
- Mark GotfriedPhoenix$196K
- Rajeev SaggarPhoenix$161K
- Gregory AhearnPhoenix$144K
- Jagruti PatelPhoenix$141K
- Ali SaeedPhoenix$138K
- Ramit SharmaPhoenix$65K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.